MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 27.12.2025
OrganiGram Holdings ROA 2011-2025 | OGI
ROA Jährlich OrganiGram Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -23.59 | -31.29 | -2.23 | - | - | 1.57 | - | -171.01 | -111.43 | -27.95 | -26.67 |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.57 | -171.01 | -49.07 |
ROA anderer Aktien in der Arzneimittelhersteller
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
-13.11 | - | - | $ 142 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
-17.34 | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
-65.18 | $ 1.21 | -7.63 % | $ 130 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
-71.31 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
-242.23 | - | 0.86 % | $ 117 M | USA |
 |
Cronos Group
CRON
|
-3.8 | $ 2.67 | -2.55 % | $ 1.44 B | Canada |
 |
Catalent
CTLT
|
-10.69 | - | - | $ 11.5 B | USA |
 |
Agile Therapeutics
AGRX
|
-141.05 | - | 10.11 % | $ 58.2 M | USA |
 |
DURECT Corporation
DRRX
|
-61.13 | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
8.78 | - | -39.89 % | $ 27.7 M | USA |
 |
Aurora Cannabis
ACB
|
-26.69 | $ 4.47 | -2.08 % | $ 86.3 M | Canada |
 |
Endo International plc
ENDP
|
-47.69 | - | - | $ 28.9 M |  Irlanda |
 |
Zomedica Corp.
ZOM
|
-13.64 | - | -0.21 % | $ 98 M | USA |
 |
Evoke Pharma
EVOK
|
-110.24 | - | - | $ 36.6 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-34.9 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-8.75 | - | 2.45 % | $ 38.1 M | Canada |
 |
Zynerba Pharmaceuticals
ZYNE
|
-63.1 | - | - | $ 55.5 M | USA |
 |
Emergent BioSolutions
EBS
|
-41.71 | $ 12.36 | -2.37 % | $ 633 M | USA |
 |
Athenex
ATNX
|
-50.69 | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
-29.73 | $ 21.6 | 0.07 % | $ 2.06 B |  France |
 |
Evolus
EOLS
|
-21.68 | $ 6.88 | 0.36 % | $ 427 M | USA |
 |
Harrow Health
HROW
|
-7.82 | $ 50.08 | -0.16 % | $ 1.63 B | USA |
 |
China Pharma Holdings
CPHI
|
-31.81 | $ 1.29 | -1.56 % | $ 22.5 M |  China |
 |
Neoleukin Therapeutics
NLTX
|
6.13 | - | - | $ 193 M | Canada |
 |
Bausch Health Companies
BHC
|
-2.16 | $ 7.19 | -0.07 % | $ 2.62 B | Canada |
 |
Lannett Company
LCI
|
-47.81 | - | 1.15 % | $ 7.11 M | USA |
 |
Organogenesis Holdings
ORGO
|
0.17 | $ 5.36 | -8.71 % | $ 706 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-2.52 | $ 4.11 | -2.14 % | $ 57.8 M | USA |
 |
Pacira BioSciences
PCRX
|
-6.41 | $ 26.48 | 1.77 % | $ 1.22 B | USA |
 |
Sundial Growers
SNDL
|
-16.12 | $ 1.75 | -1.13 % | $ 3.37 M | Canada |
 |
PetIQ
PETQ
|
0.25 | - | 1.64 % | $ 400 M | USA |
 |
Jupiter Wellness
JUPW
|
-673.3 | - | - | $ 33.6 M | USA |
 |
Perrigo Company plc
PRGO
|
-1.78 | $ 13.87 | 0.95 % | $ 1.91 B | USA |
 |
ProPhase Labs
PRPH
|
21.06 | $ 0.51 | -16.94 % | $ 8.08 M | USA |
 |
Radius Health
RDUS
|
-38.66 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-8.65 | - | -4.76 % | $ 65.3 M | USA |
 |
Relmada Therapeutics
RLMD
|
-101.27 | $ 4.5 | -2.21 % | $ 135 M | USA |
 |
Rockwell Medical
RMTI
|
-16.18 | $ 0.87 | 7.18 % | $ 20.3 M | USA |
 |
OptiNose
OPTN
|
-32.94 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-115.89 | $ 9.92 | 0.22 % | $ 705 M | USA |
 |
PLx Pharma
PLXP
|
-60.18 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-66.1 | $ 5.83 | -1.19 % | $ 238 M | USA |
 |
SCYNEXIS
SCYX
|
52.21 | $ 0.58 | -1.87 % | $ 27.8 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-25.25 | $ 3.63 | -0.41 % | $ 4.5 M | USA |
 |
Tricida
TCDA
|
-104.78 | - | - | $ 3.25 M | USA |
 |
Tilray
TLRY
|
-33.73 | $ 9.6 | -5.43 % | $ 5.93 B | Canada |
 |
TherapeuticsMD
TXMD
|
-23.73 | $ 1.72 | 0.88 % | $ 18 M | USA |
 |
Veru
VERU
|
-62.57 | $ 2.37 | 1.28 % | $ 320 M | USA |
 |
Viatris
VTRS
|
4.16 | $ 12.33 | 0.69 % | $ 14.9 B | USA |